X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (493) 493
Publication (52) 52
Book Review (11) 11
Book Chapter (8) 8
Conference Proceeding (2) 2
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
vedolizumab (483) 483
index medicus (249) 249
ulcerative colitis (245) 245
maintenance therapy (241) 241
inflammatory bowel disease (218) 218
gastroenterology & hepatology (198) 198
crohn's disease (178) 178
infliximab (154) 154
humans (151) 151
ulcerative-colitis (144) 144
crohns-disease (140) 140
induction (120) 120
inflammatory-bowel-disease (109) 109
adalimumab (92) 92
antibodies, monoclonal, humanized - therapeutic use (84) 84
induction therapy (75) 75
crohn’s disease (71) 71
natalizumab (69) 69
colitis, ulcerative - drug therapy (64) 64
gastrointestinal agents - therapeutic use (63) 63
crohn disease - drug therapy (60) 60
male (59) 59
female (58) 58
pharmacology & pharmacy (57) 57
ustekinumab (57) 57
inflammatory bowel diseases (54) 54
adult (52) 52
remission (49) 49
inflammatory bowel diseases - drug therapy (47) 47
management (46) 46
treatment outcome (46) 46
integrin (42) 42
antibodies, monoclonal, humanized - adverse effects (41) 41
safety (40) 40
therapy (40) 40
tumor necrosis factor-alpha - antagonists & inhibitors (40) 40
gastroenterology (39) 39
care and treatment (38) 38
golimumab (38) 38
middle aged (37) 37
efficacy (36) 36
immunology (34) 34
patients (34) 34
anti-tnf (32) 32
combination therapy (31) 31
tofacitinib (31) 31
biologics (30) 30
gastrointestinal agents - adverse effects (30) 30
integrins (30) 30
progressive multifocal leukoencephalopathy (30) 30
analysis (29) 29
double-blind (29) 29
animals (28) 28
medicine & public health (28) 28
azathioprine (27) 27
medical research (26) 26
monoclonal antibodies (26) 26
remission induction (26) 26
monoclonal-antibody (25) 25
clinical trials (24) 24
tumor necrosis factor (24) 24
active crohns-disease (23) 23
colon (23) 23
drug therapy (23) 23
medicine, general & internal (23) 23
surgery (23) 23
certolizumab pegol (22) 22
clinical-response (22) 22
integrins - antagonists & inhibitors (22) 22
tumor necrosis factor-tnf (22) 22
article (21) 21
colitis (21) 21
corticosteroids (21) 21
young adult (21) 21
anti-tnf therapy (20) 20
crohns disease (20) 20
evidence-based consensus (20) 20
medicine, experimental (20) 20
pharmacokinetics (20) 20
systematic review (20) 20
abridged index medicus (19) 19
antibodies, monoclonal, humanized - pharmacology (19) 19
endoscopy (19) 19
health aspects (19) 19
humanized antibody (19) 19
ibd (19) 19
intestine (19) 19
original (19) 19
retrospective studies (19) 19
severity of illness index (19) 19
antibody (18) 18
biological products (18) 18
outcomes (18) 18
risk (18) 18
antibodies, monoclonal - therapeutic use (17) 17
biological therapy (17) 17
etrolizumab (17) 17
gastroenterology and hepatology (17) 17
inflammation (17) 17
madcam-1 (17) 17
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (459) 459
German (17) 17
Spanish (12) 12
Czech (6) 6
French (4) 4
Russian (3) 3
Korean (2) 2
Polish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Inflammatory Bowel Diseases, ISSN 1078-0998, 11/2012, Volume 18, Issue 11, pp. 2107 - 2119
Journal Article
ANNALS OF THE RHEUMATIC DISEASES, ISSN 0003-4967, 12/2018, Volume 77, Issue 12
Journal Article
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, ISSN 1542-3565, 03/2019
We performed a systematic review and meta-analysis to evaluate the comparative risk of serious infections with tumor necrosis factor (TNF) antagonists, non-TNF... 
Journal Article
GASTROENTEROLOGY, ISSN 0016-5085, 09/2019, Volume 157, Issue 3, pp. 894 - 894
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2019
Background & AimsWe performed a systematic review of changes in fecal and colon microbiomes of patients with inflammatory bowel diseases (IBD) receiving... 
Gastroenterology and Hepatology
Journal Article
Journal of Crohn's & colitis, ISSN 1873-9946, 06/2019
Journal Article
INFLAMMATORY BOWEL DISEASES, ISSN 1078-0998, 03/2017, Volume 23, Issue 3, pp. 379 - 391
Background: The precise mechanisms controlling homing of T effector (Teff) cells to the inflamed gut in Crohn's disease (CD) are still unclear, and clinical... 
vedolizumab | VEDOLIZUMAB INDUCTION THERAPY | inflammatory bowel diseases | ULCERATIVE-COLITIS | SMALL-INTESTINE | T cells | MAINTENANCE THERAPY | ADHESION MOLECULE-1 | INFLAMMATORY-BOWEL-DISEASE | gut homing | BINDING-SITES | META-ANALYSIS | GASTROENTEROLOGY & HEPATOLOGY | CLINICAL-PRACTICE | natalizumab
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 05/2018, Volume 16, Issue 5, pp. 697 - 705.e7
There are few data available on the real-life pharmacokinetic and pharmacodynamics features of vedolizumab, a monoclonal antibody against integrin α4β7. We... 
Clinical Outcome | Trough Level | IBD | Clinical Response | Vedolizumab | Immunogenicity
Journal Article
Inflammatory Bowel Diseases, ISSN 1078-0998, 07/2019, Volume 25, Issue 8, pp. 1375 - 1382
Abstract Background Combined therapy with vedolizumab and corticosteroids may improve clinical response or remission in Crohn’s disease. The aim of this study... 
Original Clinical | vedolizumab | induction | corticosteroids | Crohn’s disease
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 05/2018, Volume 24, Issue 17, pp. 1868 - 1880
In inflammatory bowel disease (IBD), tumor necrosis factor plays an important role in mediating inflammation, but several other pathways are also involved in... 
Inflammatory bowel disease | Abrilumab | Integrin | Natalizumab | Etrolizumab | Vedolizumab | PF00547659 | AJM300 | Crohn’s disease | Ulcerative colitis | VEDOLIZUMAB INDUCTION THERAPY | ANTAGONIST | EFFICACY | PF-00547659 | ULCERATIVE-COLITIS | Crohn's disease | ACTIVE CROHNS-DISEASE | MAINTENANCE THERAPY | ENDOTHELIAL-CELLS | DOUBLE-BLIND | GASTROENTEROLOGY & HEPATOLOGY | EXPRESSION | Minireviews
Journal Article
The American Journal of dermatopathology, ISSN 0193-1091, 3/2018, Volume 40, Issue 3, pp. e36 - e37
Erythema induratum (EI), or nodular vasculitis (NV), is a type of panniculitis that is often associated with vasculitis affecting various-sized veins, venules,... 
vedolizumab | erythema induratum | nodular vasculitis
Journal Article
Journal of Pediatric Surgery, ISSN 0022-3468, 10/2019, Volume 54, Issue 10, pp. 2162 - 2165
Limited knowledge exists as to what impact preoperative biologic therapy has on postoperative complications in pediatric patients undergoing abdominal surgery... 
Anti-TNF | Ustekinumab | Crohn's disease | Vedolizumab | Postoperative outcomes | SURGERY | VEDOLIZUMAB INDUCTION THERAPY | ILEOCOLONIC RESECTION | ULCERATIVE-COLITIS | ALPHA | RISK | INFLIXIMAB THERAPY | ABDOMINAL-SURGERY | INFLAMMATORY-BOWEL-DISEASE | PEDIATRICS | COMPLICATIONS | OUTCOMES | Monoclonal antibodies | Pediatrics | Children | Tumor necrosis factor | Health aspects | Morbidity
Journal Article
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, ISSN 0815-9319, 06/2016, Volume 31, pp. 4 - 5
Journal Article
Journal of Crohn's and Colitis, ISSN 1873-9946, 04/2018, Volume 12, Issue 5, pp. 621 - 626
Abstract Background and Aims Medical management of fistulising Crohn’s disease [CD] is constrained by the limited number of available therapies. We evaluated... 
Short Report | Vedolizumab | fistula | Crohn’s disease
Journal Article
JOINT BONE SPINE, ISSN 1297-319X, 03/2018, Volume 85, Issue 2, pp. 255 - 256
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.